Aethlon Medical, Inc. (NASDAQ:AEMD) has seen 1,468,190 shares traded in the last trading session. The company, currently valued at $19.39 Million, closed the last trade at $2.07 per share which meant it lost -$0.32 on the day or -13.39% during that session. The AEMD stock price is -334.78% off its 52-week high price of $9 and 63.29% above the 52-week low of $0.76. If we look at the company’s 10-day average daily trading volume, we find that it stood at 16.85 Million shares traded. The 3-month trading volume is 2.43 Million shares.

The consensus among analysts is that Aethlon Medical, Inc. (AEMD) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.16.

Aethlon Medical, Inc. (NASDAQ:AEMD) trade information

Despite being -13.39% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Jun 22 when the AEMD stock price touched $2.60-2 or saw a rise of 20.38%. Year-to-date, Aethlon Medical, Inc. shares have moved 114.95%, while the 5-day performance has seen it change -21.89%. Over the past 30 days, the shares of Aethlon Medical, Inc. (NASDAQ:AEMD) have changed 58.02%. Short interest in the company has seen 283.83 Million shares shorted with days to cover at 116.8.

Wall Street analysts have a consensus price target for the stock at $45, which means that the shares’ value could jump 2073.91% from current levels. The projected low price target is $45 while the price target rests at a high of $45. In that case, then, we find that the current price level is +2073.91% off the targeted high while a plunge would see the stock lose 2073.91% from current levels.

Aethlon Medical, Inc. (AEMD) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +37% over the past 5 years. Earnings growth for 2020 is a modest +25.9% while over the next 5 years, the company’s earnings are expected to increase by 0%.